Suchergebnisse - "Treilleux, Isabelle"

PubPharm (286)

1

Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations

enthalten in: JAMA network open | 2024

von Schouten, P. | Schmidt, S. | Becker, K. | +20

2

p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane

enthalten in: British journal of cancer | 2024

von Vanacker, H. | Treilleux, I. | Schiffler, C. | +16

3

The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers

enthalten in: Science translational medicine | 2024

von Voissière, A. | Gomez-Roca, C. | Chabaud, S. | +17

4

BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer : state of the art and forthcoming challenges

enthalten in: Frontiers in oncology | 2024

von Collet, L. | Hanvic, B. | Turinetto, M. | +4

5

Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours

enthalten in: Bulletin du cancer | 2024

von Croce, S. | Devouassoux-Shisheboran, M. | Pautier, P. | +17

6

Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours : diagnostic implications and pitfalls

enthalten in: Histopathology | 2024

von Moura, M. | Costa, J. | Velasco, V. | +16

7

A curious biphasic breast lesion

enthalten in: Annales de pathologie | 2024

von Schoelinck, J. | Heinemann, M. | Pissaloux, D. | +2

8

The CSF-1R inhibitor Pexidartinib impacts dendritic cell differentiation through inhibition of FLT3 signaling and may antagonize the effect of durvalumab in patients with advanced cancer – results from a phase 1 study

enthalten in: bioRxiv.org | 2023

von Voissière, A. | Gomez-Roca, C. | Chabaud, S. | +17

9

MDR1-EXPRESSING CD4+ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE

enthalten in: Journal for immunotherapy of cancer | 2023

von Di Roio, A. | Hubert, M. | Besson, L. | +14

ErratumIn: J Immunother Cancer. 2023 Dec 14;11(12):. - PMID 38097344

10

Gynecological carcinosarcomas : Overview and future perspectives

enthalten in: Bulletin du cancer | 2023

von Collet, L. | González López, A. | Romeo, C. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]